Biodesix Total Assets 2020-2024 | BDSX
Biodesix Annual Total Assets (Millions of US $) |
|
---|---|
2024 | $97 |
2023 | $99 |
2022 | $93 |
2021 | $76 |
2020 | $121 |
2019 | $45 |
Biodesix Quarterly Total Assets (Millions of US $) |
|
---|---|
2024-12-31 | $97 |
2024-09-30 | $103 |
2024-06-30 | $116 |
2024-03-31 | $87 |
2023-12-31 | $99 |
2023-09-30 | $87 |
2023-06-30 | $78 |
2023-03-31 | $81 |
2022-12-31 | $93 |
2022-09-30 | $63 |
2022-06-30 | $75 |
2022-03-31 | $62 |
2021-12-31 | $76 |
2021-09-30 | $90 |
2021-06-30 | $102 |
2021-03-31 | $115 |
2020-12-31 | $121 |
2020-09-30 | $47 |
2020-06-30 | $0 |
2020-03-31 | $0 |
2019-12-31 | $0 |
2019-09-30 | $0 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.077B | $0.071B |
Biodesix Inc. is a data-driven diagnostic solutions company. It offers blood-based tests across the lung cancer continuum of care. The company also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes companion diagnostics. Biodesix Inc. is based in Boulder, Colorado. |